Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation in both kidneys and loss of renal function.
1 A 2017 review of epidemiology literature indicated a disease prevalence of approximately 3 to 4 per 10 000.
2 End-stage kidney disease, for which dialysis or kidney transplantation is needed, occurs between the fourth and seventh decade of life in the majority of affected patients.
1 Registry data collected between 1991 and 2010 showed that approximately 10% of patients receiving kidney replacement therapy had ADPKD.
3